Form 3 Biohaven Pharmaceutical For: Jun 15 Filed by: Mehta Kishan

June 17, 2021 9:51 PM EDT

Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.
Washington, D.C. 20549


Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB Number: 3235-0104
Expires: December 31, 2014
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person *
Mehta Kishan

(Last) (First) (Middle)


(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
3. Issuer Name and Ticker or Trading Symbol
Biohaven Pharmaceutical Holding Co Ltd. [ BHVN ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Shares 8,765
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Options (Right to buy)   (1) 12/18/2029 Common Shares 15,000 52.13 D  
Stock Options (Right to buy)   (2) 01/17/2029 Common Shares 20,000 37.56 D  
Restricted Share Unit Award (3)   (4)   (5) Common Shares 3,750 (3) D  
Explanation of Responses:
1. The shares subject to this stock option vest in four equal installments on December 18, 2019, 2020, 2021 and 2022, subject to the Reporting Person's continuous service with the Issuer through such vesting date.
2. The options are fully vested.
3. Each restricted share unit represents the contingent right to receive one common share of the Issuer.
4. The reporting person was granted 7,500 restricted share units on January 8, 2020, vesting in four equal installments on January 8, 2020, 2021, 2022 and 2023, subject to the reporting person's continued service with the Issuer at each vesting date.
5. Not applicable.
Exhibit 24.1 - Power of Attorney
/s/ Jim Engelhart, Attorney-in-Fact 06/17/2021
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
Exhibit 24.1
      	Know all by these presents, that the undersigned hereby 
constitutes and appoints each of Vlad 
Coric, James Engelhart and Douglas Gray, or either of them signing 
singly, and with full power of 
substitution, the undersigned's true and lawful attorney-in-fact to:
(1)	prepare, execute in the undersigned's name and on the 
undersigned's behalf, and submit to 
the U.S. Securities and Exchange Commission (the "SEC") any documents 
necessary or 
appropriate to obtain codes and passwords enabling the undersigned to 
make electronic 
filings with the SEC of reports required by Section 16(a) of the 
Securities Exchange Act of 
1934 or any rule or regulation of the SEC;
(2)	execute for and on behalf of the undersigned Forms 3, 4, and 5 
in accordance with 
Section 16(a) of the Securities Exchange Act of 1934 and the rules 
(3)		do and perform any and all acts for and on behalf of the 
undersigned which may be 
necessary or desirable to complete and execute any such Form 3, 4, or 
5, complete and 
execute any amendment or amendments thereto, and timely file such 
form with the SEC 
and any stock exchange or similar authority; and
(4)	take any other action of any type whatsoever in connection with 
the foregoing which, in the 
opinion of such attorney-in-fact, may be of benefit to, in the best 
interest of, or legally 
required by, the undersigned, it being understood that the documents 
executed by such 
attorney-in-fact on behalf of the undersigned pursuant to this Power 
of Attorney shall be in 
such form and shall contain such terms and conditions as such 
attorney-in-fact may 
approve in such attorney-in-fact's discretion.
      	The undersigned hereby grants to each such attorney-in-fact 
full power and authority to do and 
perform any and every act and thing whatsoever requisite, necessary, 
or proper to be done in the exercise 
of any of the rights and powers herein granted, as fully to all 
intents and purposes as the undersigned might 
or could do if personally present, with full power of substitution or 
revocation, hereby ratifying and 
confirming all that such attorney-in-fact, or such attorney-in-fact's 
substitute or substitutes, shall lawfully 
do or cause to be done by virtue of this power of attorney and the 
rights and powers herein granted.  The 
undersigned acknowledges that the foregoing attorneys-in-fact, in 
serving in such capacity at the request of 
the undersigned, are not assuming, any of the undersigned's 
responsibilities to comply with Section 16 of 
the Securities Exchange Act of 1934.
      	This Power of Attorney shall remain in full force and 
effect until the undersigned is no longer 
required to file Forms 3, 4, and 5 with respect to the undersigned's 
holdings of and transactions in 
securities issued by Biohaven Pharmaceutical Holding Company Ltd., 
unless earlier revoked by the 
undersigned in a signed writing delivered to the foregoing attorneys-
      	IN WITNESS WHEREOF, the undersigned has caused this Power 
of Attorney to be executed as of 
this 17th day of June, 2021.    
/s/Kishan Mehta		
Kishan Mehta		
Print Name

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

SEC Filings